{"id":752398,"date":"2023-04-27T18:46:11","date_gmt":"2023-04-27T22:46:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/"},"modified":"2023-04-27T18:46:11","modified_gmt":"2023-04-27T22:46:11","slug":"eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/","title":{"rendered":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023"},"content":{"rendered":"
\n

WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (\u201cEagle\u201d or the \u201cCompany\u201d) (Nasdaq: EGRX) today announced that the Company will release its first quarter 2023 financial results on Tuesday, May 9, 2023, before the market opens.<\/p>\n

Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows:<\/p>\n\n\n\n\n\n\n\n
Date<\/td>\n\u00a0<\/td>\nTuesday, May 9, 2023<\/td>\n<\/tr>\n
Time<\/td>\n\u00a0<\/td>\n8:30 a.m. ET<\/td>\n<\/tr>\n
Toll free (U.S.)<\/td>\n\u00a0<\/td>\n800-274-8461<\/td>\n<\/tr>\n
International\u00a0<\/td>\n\u00a0<\/td>\n203-518-9814<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Webcast (live and replay)<\/td>\n\u00a0<\/td>\n\n www.eagleus.com<\/a>, under the \u201cInvestor Relations\u201d section<\/td>\n<\/tr>\n<\/table>\n

A replay of the conference call will be available for two weeks after the call’s completion by dialing 888-566-0151 (U.S.) or 402-220-9181 (International) and entering conference call ID EGRXQ123. The webcast will be archived for 30 days at the aforementioned URL.<\/p>\n

\n About Eagle Pharmaceuticals, Inc.<\/strong>
\n \u00a0<\/strong>
\n
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients\u2019 lives. Eagle\u2019s commercialized products include vasopressin, PEMFEXY\u00ae<\/sup>, RYANODEX\u00ae<\/sup>, BENDEKA\u00ae<\/sup>, BELRAPZO\u00ae<\/sup>, TREAKISYM\u00ae<\/sup>\u00a0(Japan), and BYFAVO\u00ae<\/sup>\u00a0and BARHEMSYS\u00ae<\/sup>\u00a0through its wholly owned subsidiary Acacia Pharma Inc. Eagle\u2019s oncology and CNS\/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle\u2019s website at\u00a0www.eagleus.com<\/a>.<\/p>\n

\n Contact:<\/strong>
\n
\n Investor Relations for Eagle Pharmaceuticals, Inc:<\/strong>
\n
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com<\/u><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (\u201cEagle\u201d or the \u201cCompany\u201d) (Nasdaq: EGRX) today announced that the Company will release its first quarter 2023 financial results on Tuesday, May 9, 2023, before the market opens. Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows: Date \u00a0 Tuesday, May 9, 2023 Time \u00a0 8:30 a.m. ET Toll free (U.S.) \u00a0 800-274-8461 International\u00a0 \u00a0 203-518-9814 \u00a0 \u00a0 \u00a0 Webcast (live and replay) \u00a0 www.eagleus.com, under the \u201cInvestor Relations\u201d section A replay of the conference call will be available for two weeks after the call’s completion by dialing 888-566-0151 (U.S.) or 402-220-9181 (International) … <\/p>\n

Continue reading “Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752398","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (\u201cEagle\u201d or the \u201cCompany\u201d) (Nasdaq: EGRX) today announced that the Company will release its first quarter 2023 financial results on Tuesday, May 9, 2023, before the market opens. Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows: Date \u00a0 Tuesday, May 9, 2023 Time \u00a0 8:30 a.m. ET Toll free (U.S.) \u00a0 800-274-8461 International\u00a0 \u00a0 203-518-9814 \u00a0 \u00a0 \u00a0 Webcast (live and replay) \u00a0 www.eagleus.com, under the \u201cInvestor Relations\u201d section A replay of the conference call will be available for two weeks after the call’s completion by dialing 888-566-0151 (U.S.) or 402-220-9181 (International) … Continue reading "Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T22:46:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023\",\"datePublished\":\"2023-04-27T22:46:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/\"},\"wordCount\":252,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/\",\"name\":\"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=\",\"datePublished\":\"2023-04-27T22:46:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","og_description":"WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (\u201cEagle\u201d or the \u201cCompany\u201d) (Nasdaq: EGRX) today announced that the Company will release its first quarter 2023 financial results on Tuesday, May 9, 2023, before the market opens. Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will host a conference call to discuss the results as follows: Date \u00a0 Tuesday, May 9, 2023 Time \u00a0 8:30 a.m. ET Toll free (U.S.) \u00a0 800-274-8461 International\u00a0 \u00a0 203-518-9814 \u00a0 \u00a0 \u00a0 Webcast (live and replay) \u00a0 www.eagleus.com, under the \u201cInvestor Relations\u201d section A replay of the conference call will be available for two weeks after the call’s completion by dialing 888-566-0151 (U.S.) or 402-220-9181 (International) … Continue reading \"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T22:46:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023","datePublished":"2023-04-27T22:46:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/"},"wordCount":252,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/","name":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=","datePublished":"2023-04-27T22:46:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNzUzMiM1NTYyNDQxIzIwMTY4ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eagle-pharmaceuticals-to-host-first-quarter-2023-financial-results-on-may-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752398"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752398\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}